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ABSTRACT
Patients with mutations in the ectodysplasin receptor signalling
pathway genes – the X-linked ligand ectodysplasin-A (EDA), the
receptorEDARor the receptor adapterEDARADD – have hypohidrotic
ectodermal dysplasia (HED). In addition to having impaired
development of teeth, hair, eccrine sweat glands, and salivary and
mammaryglands,HEDpatientshaveear,noseand throatdisease.The
mouse strains Tabby (EdaTa) and downless (Edardl-J/dl-J) have rhinitis
and otitis media due to loss of submucosal glands in the upper airway.
We report that prenatal correctionofEDARsignalling inEdaTamicewith
the agonist anti-EDARantibody rescues the auditory-tube submucosal
glands and prevents otitis media, rhinitis and nasopharyngitis. The
sparse- and wavy-haired (swh) rat strain carries a mutation in the
Edaradd gene and has similar cutaneous HED phenotypes to mouse
models.We report that auditory-tube submucosal glands are smaller in
the homozygous mutant Edaraddswh/swh than those in unaffected
heterozygousEdaraddswh/+ rats, and that this predisposes them tootitis
media. Furthermore, the pathogenesis of otitis media in the rat HED
model differs from that inmice, as otitis media is the primary pathology,
and rhinitis is a later-onset phenotype. These findings in rodent HED
models imply that hypomorphic as well as null mutations in EDAR
signalling pathway genesmay predispose to otitis media in humans. In
addition, this work suggests that the recent successful prenatal
treatment of X-linked HED (XLHED) in humans may also prevent ear,
nose and throat disease, and provides diagnostic criteria that
distinguish HED-associated otitis media from chronic otitis media with
effusion, which is common in children.
KEY WORDS: EDAR signalling, Eda mouse, Edaradd rat, XLHED,
Auditory-tube submucosal gland, Otitis media
INTRODUCTION
The ectodysplasin signalling pathway comprises a TNF-like ligand
[ectodysplasin (EDA)], its transmembrane receptor (EDAR) and an
intracellular signal transducer (EDARADD). Loss of signalling due
to mutation of genes encoding any component of this linear pathway
leads to hypohidrotic ectodermal dysplasia (HED), which is
characterised by impaired development of teeth, hair, eccrine
sweat glands, and salivary and mammary glands (Kowalczyk-
Quintas and Schneider, 2014). The most common form is X-linked
HED (XLHED), caused by mutation in the EDA gene [Online
Mendelian Inheritance in Man (OMIM) number 305100], followed
by loss-of-function mutations in EDAR (OMIM 604095) or
EDARADD (OMIM 606603). Rodent models of HED carrying
comparable mutations in pathway genes include the mouse
strains Tabby [EdaTa; Mouse Genome Informatics (MGI)
number 1856197], downless (Edardl-J/dl-J; MGI:1856018) and
crinkled (Edaraddcr/cr; MGI:1856832), and the sparse and wavy
hair (swh; Edaraddswh/swh) rat (Kuramoto et al., 2005, 2011).
Humans with HED have dry nasal passages and concretion of
nasal secretions, rhino-sinusitis and nasal infection, otitis media,
speech and hearing impairment, and sore throat (Martini et al.,
1984; Shin and Hartnick, 2004; Mehta et al., 2007a,b; Callea et al.,
2013; Henningsen et al., 2014), which are attributed to impaired
development of sinonasal and auditory-tube submucosal glands
(SMGs) and reduced ciliary and salivary gland function (Callea
et al., 2013). EdaTa mice have hypoplastic submandibular salivary
glands (Jaskoll et al., 2003), and subsets of nasal/nasopharyngeal
SMGs are deleted (Grüneberg, 1971). EdaTa and Edardl-J/dl-J mice
have rhinitis, and otitis media that is associated with deletion of
auditory-tube SMGs, leading to reduced auditory-tube gating and
ascension of bacteria and foreign body (FB) particles into the bulla.
However, the ear, nose and throat pathology in human patients
differs from that in EdaTa and Edardl-J/dl-J mice, in which throat
inflammation is a relatively minor feature. In addition, ageing wild-
type rats and mice accumulate hyaline droplets in nasal and
respiratory and olfactory epithelium, and these are considered to be
an incidental finding (Chamanza and Wright, 2015), but in young
EdaTa and Edardl-J/dl-J mice these occur at an unusually high
incidence and severity (Azar et al., 2016). This change has no
counterpart in human nasal epithelium. Nasal and bulla pathology
in Edaraddcr/cr mice has not been investigated but would
presumably phenocopy EdaTa and Edardl-J/dl-J mice.
The heterozygous Edaraddswh/+ rat has a wild-type appearance,
but the homozygous Edaraddswh/swh rat shares most cutaneous and
dental phenotypes with HED mutant mouse strains. However, HED
mice have a hairless tail with a terminal tail kink, whereas
Edaraddswh/swh rats have a haired tail, a low penetrance of a terminal
tail kink and lack a bald patch behind the ear (Kuramoto et al., 2005,
2011). Nasal and bulla pathology have not been investigated in
Edaraddswh/swh rats, but differences between the nasal histology and
anatomy in mice and rats (Chamanza and Wright, 2015), as well as
rats having larger nasal passages, nasopharynx and bullae, could
conceivably alter predisposition to disease in the Edaraddswh/swh
rat model.
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phenotypes (Kowalczyk et al., 2011). The mouse auditory-gland
SMGs form at embryonic day (E)18-E19 (Grüneberg, 1971; Park
and Lim, 1992). The Edar gene is expressed in the auditory-tube
SMGs in postnatal day (P)21 EdarTg951/951 mice (Azar et al., 2016),
which have high levels of Edar expression (Majumder et al., 1998;
Mou et al., 2008; Chang et al., 2009). On the assumption that the
Edar gene is expressed in gland primordia, we hypothesized
that prenatal correction of EDAR signalling would also rescue
auditory-tube SMGs. Recently, human XLHED phenotypes
(deficient development of sweat glands and sweating function,
Meibomian glands and some tooth germ buds) have been corrected
by prenatal treatment of the fetus via intra-amniotic injection with a
recombinant protein that includes the receptor-binding domain of
EDA (Schneider et al., 2018).
This work focuses on two related aims: (1) to test whether agonist
anti-EDAR antibodies could rescue auditory-tube SMGs in EdaTa
mice and thereby prevent otitis media; and (2) to explore the
comparative nasal and bulla pathology in the Edaraddswh/swh rat.
RESULTS
Otitis media, hyaline droplet change, rhinitis and
nasopharyngitis in EdaTa mice
The frequency of rhinitis, nasopharyngitis and otitis media in
EdaTa mice at weaning age is <40% and rises to >80% at 7-17
weeks of age; hyaline droplet accumulation in nasal respiratory
epithelium is fully penetrant at weaning age (Azar et al., 2016).
To standardize experimental observations, we therefore chose an
early time point of P21-P22 and a late time point of P79-P90,
when pathology approaches maximal penetrance. Initially, we
examined untreated EdaTa mice and the spontaneous background
pathology in FVB mice (the background inbred genetic line for
the EdaTa strain). Untreated P21 (n=12) and P79-P90 (n=13)
EdaTa mice had typical features of HED characterised by sparse
hair coat and a hairless tail with a terminal kink. Auditory-tube
SMGs were deleted in all P21 and P79-P90 EdaTa mice, and the
proportion of bullae with histological otitis media was 0.38 (9/
24) at P21 and 0.61 (16/26) at P79-P90. The bulla cavity
contained serous bulla effusion at P21 (Fig. 1). The proportion of
P21 and P79-P90 EdaTa mice with nasal inflammation (rhinitis)
was 0.33 (4/12) and 0.85 (11/13), and inflammation of the
nasopharynx (nasopharyngitis) 0.75 (9/12) and 0.77 (10/13),
respectively. All EdaTa mice had hyaline droplet accumulation in
nasal respiratory epthelium. FVB (n=13 P21 and n=10 P81-P84)
control mice had normal wild-type hair coats and tails,
histologically normal cutaneous and auditory-tube SMGs, and
nasal, nasopharynx and bulla pathology was absent, whereas
hyaline droplet change was evident in a low proportion (0.2) at
P81-P84 (Fig. 2).
Fig. 1. Prenatal treatment with agonist anti-EDAR antibody rescues auditory-tube submucosal glands (SMGs) and otitis media in EdaTa mice.
(A-D) Untreated P21 EdaTa mice. (E-H) P21-P22 EdaTa mice treated with agonist anti-EDAR antibody (mAbEDAR1). (I-L) P82-P84 EdaTa mice treated with
isotype control Aprily-2 (mouse IgG1 anti-hAPRIL). (M-P) P85 EdaTa treated with mAbEDAR1. Rhinitis (A,I,J) is characterised by heavy inflammatory cell
exudation into the nasal cavity and is prevented (E,F) by mAbEDAR1 treatment except in a single P85-treated mouse shown (M,N), in which there is light
infiltration of mucosa with inflammatory cells (shown in N). (B,F,J,N) Hyaline droplet change in nasal respiratory epithelium occurs in untreated, mAbEDAR1
and Aprily-2-treated mice. mAbEDAR1 rescues auditory-tube SMGs (G,O) and prevents otitis media (H,P). Otitis media is characterised by serous effusion
in untreated P21 EdaTa mice (D) and suppurative exudation in Aprily-2-treated P85 EdaTa mice (L), whereas (H,P) P21 and P85 EdaTa mAbEDAR1-treated
mice have healthy air-filled bulla cavity lined by slender mucosa. Panels E and F, I and J, K and L, and M and N are low- and high-magnification image
pairs. at, auditory tube; bc, bulla cavity; ex, exudate; hd, hyaline droplets; ic, inflammatory cells; nc, nasal cavity; np, nasopharynx; se, serous effusion;
smg, submucosal gland. Scale bars: (C,G,K,O) 200 µm; (A,E,I,M) 100 µm; (B,D,F,H,J,L,N,P) 50 µm.
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Otitis media is rescued in EdaTamice by agonist anti-EDAR
antibodies
Prenatal treatment
In keeping with Grüneberg (1971) and Park and Lim (1992), we
found gland primordia in E18.5 wild-type mice. Primordia appear as
tissue buds that extend from the nasopharynx and auditory-tube
epithelium into submucosal connective tissue. E18.5 gland primordia
show high expression of the Edar gene by in situ hybridization (ISH),
but relatively low expression of Foxj1 (a ciliated cell marker)
and Bpifa1 (an antibacterial/surfactant product of the adult murine
SMG acini; Bartlett et al., 2015). P1 gland primordia stain by
immunohistochemistry (IHC) for keratin 5 (K5), K8 and K19, and
have a laminin-positive basal lamina (Fig. S1). K5-positive basal
cells are a putative stem cell phenotype; K8 is a primary keratin and
K19 is a secondary keratin of simple epithelial cells.
In agreement with Kowalczyk et al. (2011), we found that
prenatal administration of mAbEDAR1 to pregnant EdaTa females
at E10.5 and E17.5 rescued the major macroscopic cutaneous HED
phenotypes in 11 (n=2 P22 and n=9 P85) offspring mice; a minor
tail kink was observed in one treated EdaTa pup but the remainder
had wild-type cutaneous features. In addition, we found that
auditory-tube SMGs were rescued by prenatal treatment in all (n=2)
P22 and (n=9) P85 mice. Otitis media and nasopharyngitis were
absent in all treated EdaTa mice. One of nine mice at P85 had mild
rhinitis (Fig. 1). Hyaline droplet change was present in 2/2 P22 and
5/9 P85 treated EdaTa mice (Fig. 2).
Pre- and postnatal treatment
Nasal respiratory mucosa hyaline droplet accumulation is a
postnatal phenotype. It was absent in P5 (n=1) and P6 (n=2)
EdaTa mice but fully penetrant in untreated P21-P22 EdaTa mice.
We therefore tested a pre- and postnatal mAbEDAR1 dosage
regimen by treating six pups at P1, P7 and P14 (in addition to E10.5
and E17.5) with the specific aim of seeing whether this could also
rescue hyaline droplet change. Cutaneous HED phenotypes were
rescued in all but one of six P21 EdaTa pups that had a sparse hair
coat. As expected from the previous experiment, auditory-tube
SMGs, rhinitis and nasopharyngitis were rescued in 6/6 mice; none
had otitis media. However, hyaline droplet change remained fully
penetrant and this raised the question of whether nasal respiratory
epithelium and medial nasal glands were capable of responding to
EDAR signalling during the postnatal period. We tested this by
showing Edar ISH signals at P5 (Fig. S1).
Isotype control antibodies fail to rescue upper respiratory
tract phenotypes in EdaTa mice
Isotype control antibody (Aprily-2) was administered to two
pregnant EdaTa females and all (n=10) offspring had typical
cutaneous, upper airway and bulla HED phenotypes at P82-P84.
The affected proportions were 0.8, 1, 0.9 and 0.60 for rhinitis, nasal
hyaline droplet change, nasopharyngitis and otitis media,
respectively, and otitis media was characterised by suppurative
exudation (Figs 1,2). We also confirmed the presence of Meibomian
glands, footpad eccrine sweat glands and tail hair follicles with
sebaceous glands in the mAbEDAR1 treatment groups, and their
absence in Aprily-2-treated EdaTa mice (Fig. S2).
Otitismedia inEdaraddswh/swh rats is associatedwith smaller
auditory-tube SMGs
Auditory-tube SMGs were present in Edaraddswh/swh rats (n=21),
but were not apparent in serial sections of one P0 pup. In a
qualitative comparison between two P10 littermates, the SMGs
Fig. 2. Prevalence of nasal, nasopharynx and bulla pathology in EdaTa
mice. Proportions of FVB and EdaTa mice with (A) rhinitis, (B) hyaline
droplet change in nasal respiratory epithelium, (C) nasopharyngitis and
(D) otitis media. The prevalence of rhinitis, nasopharyngitis and otitis
media is significantly reduced by treatment with mAbEDAR1 in (n=2 prenatal
only, and n=6 pre- and postnatally treated) P21-P22 EdaTa mice and in P85
EdaTa mice, compared to untreated and Aprily-2-antibody-treated controls.
mAbEDAR1 treatment reduced the prevalence of hyaline droplet change at
P85. FVB mice had no rhinitis, nasopharyngitis or otitis media, and hyaline
droplet changewas only evident in a small proportion of FVBmice at P81-P84.
The numbers in the body of the graphs represent the number of tissues
examined (nasal, nasopharynx and bullae) in each cohort. The histogram
bar represents themean proportion, and error bars the 95% confidence interval
for each proportion. Frequency data were analysed with Fisher’s exact tests.
Two-tailed tests; ns, not significant (P>0.05), *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001.
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appeared smaller in the Edaraddswh/swh pup than those in the
Edaradd+/+ littermate (Fig. 3). The auditory-tube SMGs appear as
nests and sheets of cells separated by bands of striated muscle. The
glandular epithelium includes serous acini and Alcian Blue (AB)-
positive mucous cells. Serous cells have periodic acid schiff (PAS)-
positive cytoplasmic granules that are also positive for the
antibacterial/surfactant protein Bpifa1 (Fig. S3). Auditory-tube
SMGs in P21, P42 and P83-P85 Edaraddswh/swh rats had smaller
area profiles compared to those in aged-matched Edaraddswh/+
littermates (Figs 3,4). P83-P85 Edaraddswh/swh auditory-tube SMGs
had a smaller area of PAS-positive acini but the reduction in
AB-positive mucus did not achieve statistical significance (Figs 3,4,
Fig. S3). Nasopharynx widths were comparable between genotypes
and were ∼1.2 mm, ∼1.9 mm and ∼2.4 mm at P21, P42 and
P83-P85, respectively, in aged-matched littermates (Fig. 4).
Up until P21, Edaraddswh/swh bullae were healthy (n=2 P0, n=2
P10, n=2 P13, n=6 P21) but otitis media was observed in 1/10, 6/8,
7/8 and 4/4 bullae at P30, P42, P83-P85 and P226-P250,
respectively. Littermate controls had normal healthy bullae (n=8
P21, n=2 P30, n=8 P42, n=8 P83-P85 Edaraddswh/+; n=4 P83-P84
Edaradd+/+) (Fig. 4). Otitis media in >P42 Edaraddswh/swh rats is
characterised by suppurative exudation into the bulla cavity,
inflammatory thickening of the bulla mucosa, granulation tissue
formation, macrophage and multinucleate giant cell reaction to FB
Fig. 3. Auditory-tube submucosal gland (SMG) changes in Edaraddswh/swh rats are associated with nasal, nasopharynx and bulla pathology.
(A,B) Auditory-tube SMGs are not apparent in a P0 Edaraddswh/swh rat, and reduced in size at P10 (C,D) and P21 (E-H) compared to Edaraddswh/+ rats.
(I,J) Nasal respiratory epithelium is similar in P85 Edaraddswh/+ and Edaraddswh/swh rats, with numerous goblet cells (AB-PAS stain), and rhinitis and
hyaline droplet change are absent. (K,L) P226 Edaraddswh/swh rat with rhinitis associated with (K) mucosal inflammation and (L) FB particles and exudation
into the nasal passages (AB-PAS stain). (M) The nasopharynx of the P21Edaraddswh/+ rat is lined with goblet cells but in (N) P21Edaraddswh/swh, epithelial goblet
cells are lost and there is an inflammatory cell infiltration in submucosal connective tissue. (O) P226 Edaraddswh/swh nasopharynx with epithelial squamous
metaplasia and (P) intraluminal FB particles (AB-PAS stain). (Q) Healthy air-filled bulla cavity in a P85 Edaraddswh/+ rat, and otitis media in Edaraddswh/swh
bullae at P85 (R) and P226 (S) characterized by intraluminal exudation and inflamed granulation tissue and mucous cell hyperplasia (AB-PAS stain).
(T) Higher-power magnification of mucous cell hyperplasia (AB-PAS stain). (U) Normal slender mucosa in a P85 Edaraddswh/+ bulla. (V) P85 Edaraddswh/swh
bulla mucosa with ciliated-cell hypertrophy and thickened mucosa. (W) P226 Edaraddswh/swh bulla mucosa with lymphocyte and plasma cell infiltrates.
(X) FB and multinucleate giant cell reaction in granulation tissue in a P85 Edaraddswh/swh bulla (AB-PAS stain). at, auditory tube; bb, bulla bone; bc, bulla cavity;
ex, exudate; fb, foreign body; gc, goblet cell; gt, granulation tissue; ic, inflammatory cells; mch, mucous cell hyperplasia; mng, medial nasal gland; mngc,
multinucleate giant cell; muc, mucosa; nc, nasal cavity; np, nasopharynx; sqm, squamous metaplasia; smg, submucosal gland; tm, tympanic membrane.
Scale bars: (A,E,G,Q-S) 1000 µm; (F,H) 500 µm; (B-D,L) 200 µm; (X) 100 µm; (I-K,M-P,T-W) 50 µm.
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particles, and, in two (P226 and P250) Edaraddswh/swh rats, marked
mucous cell hyperplasia (Fig. 3).
Unlike EdaTa mice, the nasal respiratory epithelium in
Edaraddswh/swh rats did not show hyaline droplet change, and
rhinitis was absent or minimal in animals up to P83-P85. P21, P30,
P42 and P83-P85 Edaraddswh/swh rats had neutrophil infiltration of
nasopharynx mucosa. Two (P226 and P250) Edaraddswh/swh
females had marked rhinitis, nasopharyngitis with squamous
metaplasia; one of these also had a heavy load of FB particles in
the nasopharynx lumen (Fig. 3), and both had FB particles in the
auditory-tube lumen.
Edaradd expression in rat tissues and HED phenotypes in
Edaradd swh/swh rats
Edaradd ISH signals were detected in P10 Edaradd+/+ auditory-tube
SMGs, nasopharyngeal epithelium and the Zymbal’s gland
associated with the outer ear canal, but expression in nasal
respiratory epithelium and medial nasal glands was low (Fig. 5).
The histological features of HED in Edaraddswh/swh rats were
essentially those described by Kuramoto et al. (2005, 2011).
However, we found hypoplastic foci of eccrine sweat glands in
some footpad sections, and some tongue sections had serous SMGs
(Fig. S4). The Edaradd gene was expressed in these tissues in P13
Edaraddswh/+ rats, as well as in Meibomian glands and conjunctiva
epithelium, the ductal epithelium in submandibular and sublingual
salivary glands, anagen hair follicles, and whisker follicles, but
expressionwasweak in sebaceous glands and tracheal glands (Fig. 5).
DISCUSSION
We report that prenatal administration of agonist anti-EDAR
antibody to EdaTa mice rescues rhinitis, nasopharyngitis,
auditory-tube SMGs and otitis media. These results provide
further evidence for the importance of EDAR signalling in
murine upper respiratory tract SMG development, and the role of
these glands in the protection of nasal cavity, nasopharynx and
bullae (Azar et al., 2016). We also demonstrate the first non-vaccine
intervention to prevent otitis media in an animal model. Auditory-
tube SMG primordia arise at E18-E19 (Grüneberg, 1971; Park and
Lim, 1992) but are missing in EdaTa mice (Grüneberg, 1971). We
show that the Edar gene is expressed in wild-type E18.5 gland
primordia. We infer that prenatal (E10.5 and E17.5) administration
of agonist anti-EDAR antibody acts via the receptor EDAR to
initiate gland primordia growth in EdaTa mice. Prenatal rescue of
auditory-tube SMGs provides long-term bulla protection, indicating
that continuous EDAR signalling is not required for adult gland
function. Auditory-tube SMGs are present in newborn children
(Orita et al., 2002; Berger, 1993), implying that novel prenatal
correction of XLHED phenotypes (Schneider et al., 2018) may also
aid upper respiratory tract SMG development, thereby reducing
predisposition to chronic nasal and bulla pathology.
Hyaline droplets arise in EdaTa nasal respiratory epithelium
between P5/P6 and P21/P22 but are only evident at a low level in
>P80 FVB mice. Edar is expressed in P5 EdaTa nasal respiratory
epithelium and medial nasal glands, albeit at lower levels than
embryonic auditory-tube gland primordia, suggesting that nasal
epithelia are potentially responsive to EDAR signalling. However
(pre- and) postnatal (P1, P7 and P14) administration of agonist anti-
EDAR antibody does not rescue hyaline droplet change at P21, but
there appears to be a partial rescue of hyaline droplet change at P85.
This may represent an effect of EDAR signalling on basal cells that
give rise to mature ciliated respiratory epithelium cells in normal cell
turnover. Agonist anti-EDAR antibody treatment reduces rhinitis
Fig. 4. Otitis media in Edaraddswh/swh rats is associated with smaller
auditory-tube submucosal glands (SMGs). (A) The prevalence of otitis
media in Edaraddswh/swh rats is indicated by the proportion of affected bullae
and increases significantly from P30 to P42 and P83-P85 compared with
age-matched Edaraddswh/+ littermates. Data are represented as points. The
number to the left of each data point indicates the number of Edaraddswh/swh
bullae examined, and those to the right are for Edaraddswh/+ bullae. Frequency
data were analysed using Fisher’s exact tests. (B) Auditory-tube SMGs were
smaller in Edaraddswh/swh than Edaraddswh/+ rats at the P21, P42 and P83-P85
time points. Two or three rats of each genotype were analysed at each time
point. The area of each glandwasmeasured in histological step sections and the
right and left glands were measured separately. (C) In P83-P85 Edaraddswh/swh
auditory-tube SMGs, the area occupied by PAS-positive acini is reduced,
but this trend does not achieve statistical significance for AB-positive mucus.
(D) Nasopharynx width increases with age, but median width is comparable
between Edaraddswh/swh and Edaraddswh/+ for each time point. Data in graphs
B-D are represented as points and the bar the median. Data in B and C were
analysed with Mann–Whitney tests. Two-tailed tests were used throughout.
ns, not significant (P>0.05); *P<0.05, **P<0.01.
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more than hyaline droplet accumulation, suggesting that other factors
may work in concert with nasal inflammation to cause this cellular
change. Hyaline droplet change has been described in ageing rats
(St. Clair andMorgan, 1992), but we did not observe it inEdaraddswh/
swh rats with otitis media. Although the aetiology of early hyaline
droplet change in HEDmice remains unexplained, it does not appear
to be central to nasal and bulla inflammatory disease in rodentmodels.
The Edaradd gene is expressed in auditory-tube SMGs of P10
Edaradd+/+ rats. Edaraddswh/swh auditory-tube SMGs were not
apparent at birth (in the single pup examined) and were
subsequently smaller than those of Edaraddswh/+ and Edaradd+/+
littermates. A detailed embryonic study is required to establish the
normal time course of auditory-tube SMG development, but the
available data suggests that Edaraddswh/swh glands have postnatal
growth retardation. Eccrine sweat gland and tongue salivary
SMGs express the Edaradd gene and are also hypoplastic in
Edaraddswh/swh rats. This may be interpreted as support for the
suggestion that swh/swh mutation is a loss-of-function rather than a
null mutation (Kuramoto et al., 2011). In particular, Edaraddswh/swh
rats, in contrast to EdaTa mice, still have a hairy tail. Blocking
endogenous EDA protein in developing wild-type mice with
an EDA-blocking antibody induced a full-blown HED
phenotype, with the exception of the tail, which remained hairy
(Kowalczyk-Quintas et al., 2014). Residual EDAR signalling in
anti-EDA-treated mice, or in untreated Edaraddswh/swh rats, may be
sufficient to support tail hair genesis. Indeed, EDAR stimulation in
newborn EdaTa mice for as short as 3.5 h was sufficient to induce
tail hair (Swee et al., 2009). As expected, Edaradd gene expression
maps to many of the epithelia, appendages and glands that are
affected in HED.
Otitis media was not observed in Edaraddswh/+ and Edaradd+/+
rats but was first observed at P30 in Edaraddswh/swh rats, and its
prevalence increased significantly by P42. The auditory-tube SMGs
in Edaraddswh/swh rats are smaller than those in littermate control
Edaraddswh/+ rats in this critical period. Affected bullae contain
pro-inflammatory FB particles that act as fomites. The smaller
auditory-tube SMGs in P83-P85 Edaraddswh/swh rats have
significantly reduced profiles of PAS-positive acinar secretory
granules, which may translate to reduced secretion of proteins such
as antibacterial/surfactant protein Bpifa1 (Musa et al., 2012), which,
in common with the mouse, is a product of the adult auditory-tube
SMGs (Bartlett, et al., 2015). Such deficits potentially contribute to
impaired auditory-tube gating function and bulla defence. The rat
model indicates that functional deficiency, as well as deletion, of
auditory-tube SMGs can predispose to otitis media. This makes it
likely that hypomorphic as well as null mutations in EDAR
signalling pathway genes in humans will impact on gland structure
and function, and predispose individuals to otitis media.
Fig. 5. Expression of Edaradd in P10 and
P13 rat tissues. (A-D,I-K,U) P10 Edaradd+/+
and (E-H,L-T) P13 Edaraddswh/+ tissues.
ISH signals appear as red dots (unlabelled
arrowheads in B,F,H,I,K,L,N-U), and the
ISH probe is indicated in each panel.
Edaradd expression is restricted to epithelia
and glands; no signals are given with the
negative control probe DapB. The positive
control probe, PPiB, gives strong signals in
connective tissue cell populations as well as
epithelial tissues (arrowheads in K,N).
Edaradd ISH signals (arrowheads) are seen
in (B) auditory-tube SMG and epithelium
(B-D are higher-power images of A);
(E,F) Meibomian gland and conjunctiva
epithelium; (G,H) footpad with eccrine sweat
gland; (I-K) Zymbal’s gland; (L-N) tongue
SMG; (O) anagen hair follicle; (P) whisker hair
follicle; and duct epithelium in (R) sublingual
and (S) submandibular salivary glands.
Edaradd ISH signals in (Q) sebaceous gland,
(T) tracheal gland and (U) nasal respiratory
epithelium and medial nasal gland are low.
a-t smg, auditory-tube SMG; ep, epithelium;
esg, eccrine sweat gland; meg, Meibomian
gland; mng, medial nasal gland;
np, nasopharynx; sbg, sebaceous gland;
sgd, salivary gland duct; tg, tracheal gland;
zg, Zymbal’s gland. Scale bars: (G) 200 µm;
(A,E) 100 µm; (P) 50 µm; (B-D,F-O,Q-U)
20 µm.
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The pathogenesis of HED-associated otitis media differs in rat
and mouse models. Otitis media in Edaraddswh/swh rats was
established by P42 but rhinitis and impaired nasal mucociliary
clearance, marked by FB-particle accumulation in the nasopharynx,
was only observed in >P200 Edaraddswh/swh rats. In contrast, otitis
media, rhinitis and impaired mucociliary clearance are evident
in P21 EdaTa and Edardl-J/dl-J mice (Azar et al., 2016). Although
Edaraddswh/swh rats have partial auditory-tube SMG function,
the bullae are exposed to the ascension of FB particles. Better
nasal/nasopharynx mucociliary clearance in rats may be conferred
by a high density of goblet cells in the nasal septum (Chamanza
andWright, 2015) and a larger (wider) nasopharynx, up to∼2.4 mm
in P83-P85 rats compared to ∼1.2 mm in mature 10-week-old
C57BL/6J mice (Bab et al., 2007). However, larger auditory tubes
may require higher levels of SMG protection. Morphometric
analysis of auditory-tube sections is of limited value in assessing
auditory-tube function because the tube is normally closed and its
opening and closing is achieved by muscle action. Formalin fixation
can cause artefactual muscle contracture, potentially distorting the
in vivo contours of the tube.
In conclusion, we report that the agonist anti-EDAR antibody
rescues auditory-tube glands inEdaTamice and prevents rhinitis and
otitis media. There are broad similarities in HED pathology in rat
and mouse models; however, otitis media in rats is the primary
pathology and is associated with auditory-tube SMG deficiency.
Certain histological features in rats, such as mucous cell hyperplasia
in chronic otitis media, show a closer resemblance to humans and
underline the value of using diverse species models in otitis media
research (Li et al., 2013). The finding of HED-associated otitis
media in rats as well as mice suggests that dogs and cattle with HED
(Hadji Rasouliha et al., 2018; Kowalczyk et al., 2011; Waluk et al.,
2016; Karlskov-Mortensen et al., 2011; Seeliger et al., 2005) may
also have otitis media. A better understanding of interspecies
differences in HED-associated otitis media will increase the
confidence in translating findings to human patients, in which the
direct study of auditory-tube SMGs is difficult and where our
current knowledge comes from histology of post-mortem samples
(Orita et al., 2002; Berger, 1993). Rodent models and, in future,
other animal models, have an important role in modelling HED as
they have the potential to identify key characteristics of bulla
pathology, such a granulomatous inflammation induced by FB
particles, which distinguishes them from a background of acute
otitis media, recurrent acute otitis media and particularly chronic
otitis media with effusion (glue ear), which is common in infants
and young children (Bhutta et al., 2017). This understanding will
better enable the evaluation of the outcomes for novel XLHED
treatments in relatively small numbers of recipient patients.
MATERIALS AND METHODS
Mice and rat and husbandry
These studies were approved by the Roslin Institute Animal Welfare and
Ethical Review Board and performed under the authority of the appropriate
UK Home Office Project Licence. Tabby mice (EdaTa/Ta females and
EdaTa/Y hemizygous males; collectively termed EdaTa) were maintained as a
homozygous line. FVB mice are the background inbred genetic line for the
EdaTa strain and FVB/NCrl (Charles River) mice were bred to provide
control tissues. The husbandry and health surveillance of the Roslin Institute
mouse colonies was as previously described (Azar et al., 2016). Timed
mates were set up and the morning of plug is designated embryonic day 0.5
(E0.5). Male and female mice were used in all of the experiments.
The sparse and wavy hair (swh) rat strain [Kuramoto et al., 2005, 2011;
WTC-swh/Kyo, National BioResource Project (NBRP) Rat No. 0287] was
supplied by the NBRP - Rat, Kyoto University (Kyoto, Japan) and was
re-derived into the Roslin Biological Resource facility by embryo transfer
into Sprague Dawley rats. Specific pathogen-free colony rats were housed in
individually ventilated cages (Tecniplast GR1800) under a 12 h light/12 h
dark cycle, in a temperature range of 21±2°C and humidity of 55±10% with
15-20 changes of HEPA-filtered air per hour. Rats were fed irradiated
Teklad 14% Protein Rodent Diet (Harlan UK Ltd) and provided with
0.2-µm-filtered water. Rats were housed on autoclaved Aspen Chip Grade 6
bedding and cage enrichment products included Aspen wood blocks,
cardboard and plastic nesting materials.
Microbiological surveillance of sentinel rats followed Federation of
European Laboratory Animal Science Associations (FELASA) screening
guidelines and the Roslin Institute facility is free from FELASA-listed rat
viruses, bacterial pathogens and parasites.
The Edaradd rat colony was maintained by intercrossing Edaraddswh/+
rats and, out of necessity to start the colony from a small nucleus of animals,
by intercrossing Edaraddswh/swh females with Edaraddswh/+ males.
Edaraddswh/swh females have mammary hypoplasia and wean fewer pups
(Kuramoto et al., 2005). We note in our breeding programme that one
Edaraddswh/swh female weaned a total of 21 pups in 5 litters of 2-8 pups.
Male and female rats were used in all of the experiments.
Edaradd colony rats were genotyped for the mutant swh allele, which has
a C-to-T transition in exon 6 of the rat Edaradd gene, causing a change of
proline to serine at codon 153 of the protein (Kuramoto et al., 2011).
Genotyping was performed by Transnetyx using real-time PCR with the
RnEdaradd-1 Mut assay.
Administration of agonist anti-EDAR antibody and isotype
control antibodies
Two pregnant EdaTa females were administered agonist anti-EDAR antibody
(mouse IgG1 mAbEDAR1) (Kowalczyk et al., 2011) at a dose of 2 mg/kg
body weight by injections on E10.5 via an intraperitoneal injection (i.p.) and
at E17.5 via a tail-vein intravenous route (i.v.); n=2 pups were phenotyped at
P22 and n=9 were phenotyped at P85. One pregnant EdaTa female was
administered agonist antibody (E10.5 i.p. and E17.5 i.v.) and the n=6
offspring pups received 2 mg antibody/kg body weight on P1 (via a
subcutaneous route), P7 (i.p.) and P14 (i.p.); all six were phenotyped at P21.
Two pregnant EdaTa females were administered isotype control Aprily-2
(mouse IgG1 anti-hAPRIL) (Kowalczyk et al., 2011) at doses of 2 mg/kg
body weight by injections on E10.5 i.p. and at E17.5 i.v., and offspring
(n=10) were phenotyped at P82-P84. Other untreated controls included P21
FVB (n=13), P81-P84 FVB (n=10), P21 EdaTa (n=12) and P79-P90 EdaTa
(n=13) mice sampled from 2-3 litters.
Gross examination and histological sampling
EdaTa mice were scored for the macroscopic appearance of their hair coat
and tail for the presence of hair and terminal tail kink. Edaradd colony
rats were scored for HED phenotype as above for mice, noting that
Edaraddswh/swh rats differ from EDAR signalling mutant mouse strains by
having haired tails and a low penetrance of the tail kink (Kuramoto et al.,
2005). P21 [from 2 litters, 3 Edaraddswh/swh (swh/swh), 4 Edaraddswh/+
(swh/+)], P30 (1 litter, 5 swh/swh, 1 swh/+), P42 (from 3 litters, 4 swh/swh,
4 swh/+), P83-P85 (from 5 litters, 4 swh/swh, 5 swh/+, 2+/+) and two P226
and P250 Edaraddswh/swh females were examined.
Mouse tissues were fixed in neutral buffered formalin and bony tissues
were decalcified for 2-4 days in 14% EDTA. Tissues were wax embedded
for 4-µm sections and H&E staining. Haired skin from the dorsal thorax
between the shoulder blades, footpad skin, eyelid and skull were sampled
from P21-P22 (weaning-aged) mice and P79-P90 adult mice. Pooled tissues
were multiblocked for each cohort of EdaTa and FVB mice. Decalcified
skulls were prepared for dorsal plane sections of the nasal passages,
nasopharynx, auditory tubes and bullae. Nasal tissues, nasopharynx and
bullae were scored for the presence (or absence) of mucosal inflammation,
with or without intraluminal inflammatory exudate; the mucosa of inflamed
bullae is invariably thickened in otitis media. Hyaline droplet degeneration
in nasal respiratory epithelium was assessed by its presence or absence in
dorsal plane sections of the nasal septum.
Edaradd rats were sampled for histology of the eyelid, footpad skin,
dorsal thorax skin, trachea and tongue, and tissues were fixed in formalin for
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up to 7 days. Decalcification of P83-P85 skulls required up to 3 weeks
in 14% EDTA. Tissue sections were stained with H&E or Alcian
Blue-Periodic Acid Schiff (AB-PAS) stain.
Imaging
Brightfield images were acquired using a Hamamatsu NanoZoomer slide
scanner, or on an Olympus BX41 microscope equipped with a DP72 camera
and Cell D software.
Immunohistochemistry and in situ hybridization
Anti-mouse Bpifa1 rabbit polyclonal antibody (Musa et al., 2012) was a gift
from Colin Bingle (University of Sheffield, UK). IHC was performed
manually on 4-µm wax sections of P10 and P21 Edaradd rat skulls. Antigen
retrieval (citrate buffer pH 6.0) was performed on a Histos microwave
machine (100°C, 20 min); the anti-Bpifa1 rabbit primary antibody was
diluted 1/800 and applied for 30 min at room temperature, and detected with
an Envision Rabbit reagent kit for 40 min and Vector NovaRed chromogen.
ISH was performed on the Leica Bond Rx machine using RNAscope 2.5
LS probes and either a RED (catalogue number 322150) or BROWN
(322100) detection kit according to the manufacturer’s instructions
(Advanced Cell Diagnostics). P5 EdaTa skulls (fixed for 20 h and
decalcified for 8 h) were examined for Edar (Mm-Edar 423018); P10
Edaradd+/+ and P13 Edaraddswh/+ tissues (fixed for 20 h, skulls decalcified
for 48 h) for Edaradd (Rn-Edaradd 507868). Each ISH experiment was
performed alongside negativeDapB (312038) and positive PPiB (Mm-PPiB
313918; Rn-PPiB 313928) control probes.
We also examined auditory-tube SMGs in tissue sections of E18.5 and P1
wild-type mice (mixed C57BL/6J C3H background) generated in another
study (del-Pozo et al., 2019). Duplex ISH was performed on E18.5 tissues
for the non-ciliated cell marker Bpifa1 (channel 1 probe brown) and the
ciliated cell marker Foxj1 (channel 2 probe red) with a RED/BROWN kit
(322440) (del-Pozo et al., 2019). In addition, we performed separate ISH
staining for Edar and DapB. To detect single (channel 1 brown) probes
using the duplex RED/BROWNdetection system, we reduced Amp5 time to
1 min to minimize non-specific reaction (Advanced Cell Diagnostics
technical support advice). To account for the slightly higher background, we
measured Edar and DapB ISH dots in consecutive serial sections of 1
auditory-tube gland primordium from ×600 jpg images. ISH dots and cells
(nuclei) were counted with the ‘points’ tool to calculate the average number
of dots per cell. The area (pixels) of all the ISH dots, and the area of the
gland primordium, were measured with the ‘brush’ tool (Qu-Path software;
https://qupath.github.io/) (Bankhead et al., 2017). These were used to
calculate the percentage of the gland primordium area covered by Edar and
DapB ISH signals and thereby the signal-to-noise ratio.
IHC was performed on P1 tissues for laminin, and keratins 5, 8 and 19;
see del-Pozo et al. (2019) for the reagents and protocols. Histology, IHC and
ISH was performed in Easter Bush Pathology laboratories that are UK
NEQAS accredited.
Morphometric analysis of rat auditory-tube SMGs
We collected rats at P21, P42 and P83-P85 to examine the development of
Edaraddswh/swh and Edaraddswh/+ auditory-tube SMGs using 2 or 3 animals
of each genotype for each time point. Auditory-tube SMGs were serially
sectioned in dorsal plane, up through the region where the auditory tubes
bifurcate from the nasopharynx. The right and left auditory-tube SMGswere
sampled at 40-µm steps, each SMG yielding 4-7 sections to calculate an
average area per SMG. The area of the whole SMG (serous acini, mucous
glands, duct epithelium, connective tissue and myoepithelial cells) (Fig. S3)
was measured in slide scans of H&E-stained sections. Step sections
separated by 40 µm represent separate SMG cell populations. As the area
data was normally distributed, we calculated an average per slide for each
SMG. AB-PAS sections were used to measure area occupied by AB-
positive mucous and PAS-positive serous cells. For stain analysis, images
were separated into different channels using a colour deconvolution method
described in Ruifrok and Johnston (2001). Briefly, the RGB colour vectors
corresponding to each stain (AB, PAS and background) were determined
using regions of interest in a subset of the sample. The RGB values obtained
for each colour were then recorded in a macro that was used to analyse the
complete data set by producing the following values: total gland tissue
surface, total AB-stained surface and total PAS-stained surface.
Slide scanswere used tomeasure nasopharynxwidth immediately rostral to
the opening or the auditory tubes as the distance between the lateral walls
formed by the basisphenoid bones (Bab et al., 2007) using Qu-Path
(Bankhead et al., 2017) and ImageJ. The P30 cohort had only 1 Edaraddswh/+
and 5 Edaraddswh/swh rats and was excluded from the morphometric analysis.
Statistical analysis
The statistical tests were chosen after performing D’Agostino and Pearson
omnibus normality tests. Group sizes for rat SMG area datawere too small to
test for normality so we used Mann–Whitney tests for their analysis. The
summary statistics and the statistical tests used for each data set are described
in the figure legends. Fisher’s exact tests were used to compare disease
frequencies. Two-tailed tests were used throughout and test values of
P<0.05 were considered to be statistically significant. Graphs and statistics
were generated using GraphPad Prism and Vassar Stats (http://www.
vassarstats.net/).
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C., Müller, E. J., Leeb, T. and Galichet, A. (2016). A splice defect in the EDA
gene in dogs with an X-linked hypohidrotic ectodermal dysplasia (XLHED)
phenotype. G3 (Bethesda) 6, 2949-2954. doi:10.1534/g3.116.033225
9
RESEARCH ARTICLE Disease Models & Mechanisms (2019) 12, dmm037804. doi:10.1242/dmm.037804
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
